Pagina di risultati 9 per Industria: Biotecnologia Settore: Salute Mercato azionario - Quotazioni e prezzi
Elenco di tutte le azioni e i titoli con prezzi, capitalizzazione, PE ed EPS
Tutti i paesi
Tutte le borse
Salute (1574)
Biotecnologia (1574)
Mappa di calore del mercato
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS | Previsione |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS | Previsione | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||||||
Matinas BioPharma
MTNB
US
|
$0.81 — |
-10.98
|
$902.07K — | $19.10K — | $0.81 — | $0.88 — | $902.07K — | 0 | -$19.71 — |
|
|
ProtoKinetix
PKTX
US
|
$0.00 — |
0
|
$824.26K — | $2.96K — | $0.01 — | $0.01 — | $824.26K — | 0 | $0.00 — | ||
Oragenics
OGEN
US
|
$0.17 — |
-8.99
|
$776.06K — | $337.49K — | $0.17 — | $0.19 — | $776.06K — | 0 | -$1.15 — |
|
|
Protagenic Therapeutics
PTIX
US
|
$0.42 — |
-6.67
|
$760.29K — | $2.76K — | $0.42 — | $0.42 — | $760.29K — | 0.18 | $2.33 — |
|
|
SciSparc
SPRC
US
|
$0.30 — |
+11.07
|
$739.03K — | $78.28M — | $0.27 — | $0.39 — | $739.03K — | 0.0012 | $248.24 — |
|
|
IntegraGen SA
ALINT.PA
FR
|
€0.08 0.09 USD |
0
|
€491.77K 567.66K USD | €27.42K 31.65K USD | €0.07 0.08 USD | €0.08 0.09 USD | €491.77K 567.66K USD | 0 | -€0.02 -0.02 USD | ||
Magle Chemoswed Holding AB
MAGLE.ST
SE
|
SEK 0.25 0.02 USD |
-38.05
|
SEK 5.24M 511.97K USD | SEK 357.79K 34.92K USD | SEK 0.22 0.02 USD | SEK 0.44 0.04 USD | SEK 5.24M 511.97K USD | 0 | -SEK 8.23 -0.8 USD | ||
Appili Therapeutics Inc.
APLI.TO
CA
|
CA$0.00 0.0037 USD |
-50
|
CA$661.83K 491.12K USD | CA$117.00K 86.82K USD | CA$0.00 0.0037 USD | CA$0.00 0.0037 USD | CA$661.83K 491.12K USD | 0 | -CA$0.04 -0.02 USD | ||
Oxurion NV
OXUR.BR
BE
|
€0.00 0.0013 USD |
+20
|
€278.41K 321.37K USD | €271.65K 313.57K USD | €0.00 0.0011 USD | €0.00 0.0013 USD | €278.41K 321.37K USD | 0.014 | €0.08 0.09 USD | ||
Chimeric Therapeutics Limited
CHM.AX
AU
|
A$0.00 0.0020 USD |
0
|
A$442.39K 309.04K USD | A$25.13M 17.55M USD | A$0.00 0.0020 USD | A$0.00 0.0027 USD | A$442.39K 309.04K USD | 0 | -A$0.61 -0.4 USD | ||
Regen BioPharma
RGBP
US
|
$0.00 — |
0
|
$202.92K — | $250.03K — | $0.00 — | $0.00 — | $202.92K — | 0 | -$0.01 — | ||
Aditxt
ADTX
US
|
$0.00 — |
0
|
$199.60K — | $9.76M — | $0.00 — | $0.00 — | $199.60K — | 0 | $16.97M — |
|
|
Endonovo Therapeutics
ENDV
US
|
$0.00 — |
0
|
$180.76K — | $409.41K — | $0.00 — | $0.00 — | $180.76K — | 0 | $0.00 — | ||
Innovation Pharmaceuticals
IPIX
US
|
$0.00 — |
-60
|
$103.67K — | $12.60K — | $0.00 — | $0.01 — | $103.67K — | 0 | -$0.01 — | ||
BioLineRx Ltd.
BLRX.TA
IL
|
ILA 1.00 0.0029 USD |
0
|
ILA 29.87M 87.1K USD | ILA 700.00K 2.04K USD | ILA 1.00 0.0029 USD | ILA 1.00 0.0029 USD | ILA 29.87M 87.1K USD | 0 | ILA 0.00 0 USD | ||
Medigene AG
MDG1.HM
DE
|
€0.00 0.0034 USD |
-6.25
|
€44.21K 51.04K USD | €0.00 0 USD | €0.00 0.0034 USD | €0.00 0.0034 USD | €44.21K 51.04K USD | 0 | -€0.17 -0.1 USD | ||
GB Sciences
GBLX
US
|
$0.00 — |
-50
|
$40.71K — | $31.00K — | $0.00 — | $0.00 — | $40.71K — | 0 | $0.00 — | ||
Burzynski Research Institute
BZYR
US
|
$0.00 — |
0
|
$26.29K — | $60.00K — | $0.00 — | $0.00 — | $26.29K — | 0 | -$0.01 — | ||
Nascent Biotech
NBIO
US
|
$0.00 — |
-75
|
$17.22K — | $15.00K — | $0.00 — | $0.00 — | $17.22K — | 0 | $0.00 — | ||
Bio-Path
BPTH
US
|
$0.00 — |
0
|
$15.09K — | $104.00 — | $0.00 — | $0.00 — | $15.09K — | 0 | -$1.14 — | ||
Windtree Therapeutics
WINT
US
|
$0.00 — |
+50
|
$10.11K — | $70.00K — | $0.01 — | $0.01 — | $10.11K — | 0.00000061 | $484.78 — | ||
Fortress Biotech
FBIOP
US
|
$13.75 — |
-1.43
|
$0.00 — | $13.60K — | $13.42 — | $13.75 — | $0.00 — | 0 | -$0.86 — |
|
|
Regen BioPharma
RGBPP
US
|
$0.00 — |
-22.86
|
$0.00 — | $1.88M — | $0.00 — | $0.00 — | $0.00 — | 0 | -$0.02 — | ||
Vertex Pharmaceuticals Incorporated
VRTX34.SA
BR
|
R$96.21 19.5 USD |
-2.15
|
R$780.57B 158.21B USD | R$646.00 130.93 USD | R$96.21 19.5 USD | R$98.70 20 USD | R$780.57B 158.21B USD | 37.72 | R$2.55 0.52 USD | ||
Vertex Pharmaceuticals Incorporated
VRTX.MX
MX
|
MX$9,925.00 587.68 USD |
-3.08
|
MX$2.52T 149B USD | MX$76.00 4.5 USD | MX$9,925.00 587.68 USD | MX$9,925.00 587.68 USD | MX$2.52T 149B USD | 36.18 | MX$274.28 16.24 USD | ||
Vertex Pharmaceuticals Incorporated
VX1.DE
DE
|
€478.50 552.35 USD |
0
|
€121.32B 140.04B USD | €157.00 181.23 USD | €478.50 552.35 USD | €492.15 568.11 USD | €121.32B 140.04B USD | 34.95 | €13.69 15.8 USD | ||
Vertex Pharmaceuticals Incorporated
VRTX.VI
AT
|
€477.60 551.31 USD |
-2.15
|
€121.09B 139.78B USD | €22.00 25.4 USD | €477.60 551.31 USD | €491.85 567.76 USD | €121.09B 139.78B USD | 34.93 | €13.67 15.78 USD | ||
Vertex Pharmaceuticals Incorporated
VX1.F
DE
|
€469.40 541.84 USD |
-2.21
|
€119.01B 137.38B USD | €92.00 106.2 USD | €469.40 541.84 USD | €469.40 541.84 USD | €119.01B 137.38B USD | 35.16 | €13.35 15.41 USD | ||
Regeneron Pharmaceuticals, Inc.
REGN34.SA
BR
|
R$91.33 18.51 USD |
-1.28
|
R$566.87B 114.9B USD | R$146.00 29.59 USD | R$91.27 18.5 USD | R$93.72 19 USD | R$566.87B 114.9B USD | 23.12 | R$3.95 0.8 USD | ||
Regeneron Pharmaceuticals, Inc.
REGN.MX
MX
|
MX$17,710.00 1048.65 USD |
-0.51
|
MX$1.83T 108.48B USD | MX$93.00 5.51 USD | MX$17,710.00 1048.65 USD | MX$17,710.00 1048.65 USD | MX$1.83T 108.48B USD | 22.06 | MX$802.56 47.52 USD | ||
Regeneron Pharmaceuticals, Inc.
REGN.VI
AT
|
€874.00 1008.89 USD |
0
|
€90.41B 104.37B USD | €0.00 0 USD | €866.00 999.65 USD | €874.00 1008.89 USD | €90.41B 104.37B USD | 22.44 | €38.94 44.95 USD | ||
Regeneron Pharmaceuticals, Inc.
RGO.DE
DE
|
€851.50 982.92 USD |
0
|
€88.09B 101.68B USD | €6.00 6.93 USD | €851.50 982.92 USD | €868.00 1001.96 USD | €88.09B 101.68B USD | 21.86 | €38.94 44.95 USD | ||
Regeneron Pharmaceuticals, Inc.
RGO.F
DE
|
€839.10 968.6 USD |
-0.67
|
€86.80B 100.2B USD | €15.00 17.32 USD | €839.10 968.6 USD | €839.10 968.6 USD | €86.80B 100.2B USD | 21.54 | €38.94 44.95 USD | ||
Moderna, Inc.
MRNA.MX
MX
|
MX$3,830.00 226.78 USD |
+2.96
|
MX$1.55T 91.76B USD | MX$230.00 13.62 USD | MX$3,650.52 216.16 USD | MX$3,850.00 227.97 USD | MX$1.55T 91.76B USD | 0 | -MX$120.60 -7.1 USD | ||
Moderna, Inc.
MRNA.VI
AT
|
€182.48 210.64 USD |
-1.02
|
€73.84B 85.23B USD | €180.00 207.78 USD | €177.88 205.33 USD | €182.48 210.64 USD | €73.84B 85.23B USD | 0 | -€6.12 -7.06 USD | ||
Moderna, Inc.
0QF.MU
DE
|
€180.56 208.43 USD |
-1.03
|
€73.06B 84.33B USD | €0.00 0 USD | €180.56 208.43 USD | €180.56 208.43 USD | €73.06B 84.33B USD | 0 | -€6.06 -6.9 USD | ||
Moderna, Inc.
0QF.F
DE
|
€179.18 206.83 USD |
-1.34
|
€72.50B 83.69B USD | €3.00 3.46 USD | €179.18 206.83 USD | €179.20 206.86 USD | €72.50B 83.69B USD | 0 | -€6.06 -6.9 USD | ||
argenx SE
A1RG34.SA
BR
|
R$220.00 44.59 USD |
0
|
R$345.87B 70.1B USD | R$0.00 0 USD | R$220.00 44.59 USD | R$220.00 44.59 USD | R$345.87B 70.1B USD | 36.48 | R$6.03 1.22 USD | ||
CSL Limited
CSJ.F
DE
|
€118.24 136.49 USD |
-2.1
|
€56.74B 65.5B USD | €58.00 66.95 USD | €118.24 136.49 USD | €118.24 136.49 USD | €56.74B 65.5B USD | 0 | -€4.64 -5.3 USD | ||
CSL Limited
CSJA.F
DE
|
€28.40 32.78 USD |
-0.7
|
€54.51B 62.93B USD | €40.00 46.17 USD | €28.40 32.78 USD | €28.40 32.78 USD | €54.51B 62.93B USD | 0 | -€1.18 -1.3 USD | ||
argenx SE
1AEA.MU
DE
|
€860.00 992.73 USD |
-1.15
|
€54.08B 62.43B USD | €0.00 0 USD | €860.00 992.73 USD | €860.00 992.73 USD | €54.08B 62.43B USD | 34.60 | €24.85 28.69 USD | ||
UCB SA
UCB.VI
AT
|
€282.60 326.21 USD |
-1.33
|
€53.88B 62.2B USD | €0.00 0 USD | €281.50 324.95 USD | €288.20 332.68 USD | €53.88B 62.2B USD | 24.63 | €11.47 13.24 USD | ||
argenx SE
ARGX.VI
AT
|
€853.00 984.65 USD |
0
|
€53.64B 61.92B USD | €0.00 0 USD | €853.00 984.65 USD | €861.20 994.11 USD | €53.64B 61.92B USD | 33.94 | €25.13 29.01 USD | ||
UCB SA
UNC.F
DE
|
€280.30 323.56 USD |
-2.03
|
€53.44B 61.69B USD | €1.00 1.15 USD | €280.30 323.56 USD | €280.30 323.56 USD | €53.44B 61.69B USD | 24.76 | €11.32 13.07 USD | ||
CSL
CMXHF
US
|
$128.26 — |
0
|
$61.55B — | $500.00 — | $135.00 — | $135.00 — | $61.55B — | 0 | -$5.35 — |
|
|
UCB
UCBJF
US
|
$322.09 — |
+0.72
|
$61.41B — | $777.00 — | $325.00 — | $325.00 — | $61.41B — | 24.56 | $13.11 — |
|
|
argenx SE
1AE.F
DE
|
€845.60 976.11 USD |
-1.67
|
€53.18B 61.38B USD | €1.00 1.15 USD | €845.60 976.11 USD | €845.60 976.11 USD | €53.18B 61.38B USD | 34.02 | €24.85 28.69 USD | ||
argenx
ARGNF
US
|
$965.00 — |
0
|
$60.69B — | $49.00 — | $995.00 — | $995.00 — | $60.69B — | 33.42 | $28.87 — |
|
|
argenx SE
1AEA.F
DE
|
€810.00 935.01 USD |
-1.82
|
€50.94B 58.8B USD | €2.00 2.31 USD | €810.00 935.01 USD | €810.00 935.01 USD | €50.94B 58.8B USD | 32.59 | €24.85 28.69 USD | ||
Samsung Biologics Co.,Ltd.
207940.KS
KR
|
₩1,355,000 1022.8 USD |
-1.45
|
₩66T 49.62B USD | ₩44K 32.92 USD | ₩1,321,000 997.14 USD | ₩1,382,000 1043.18 USD | ₩66T 49.62B USD | 0 | ₩0 0 USD | ||
BeOne Medicines AG
49BA.F
DE
|
€348.00 401.71 USD |
-3.72
|
€39.75B 45.89B USD | €15.00 17.32 USD | €348.00 401.71 USD | €348.00 401.71 USD | €39.75B 45.89B USD | 51.86 | €6.71 7.75 USD | ||
Royalty Pharma plc
RPRXN.MX
MX
|
MX$1,213.52 71.86 USD |
0
|
MX$697.76B 41.32B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$697.76B 41.32B USD | 44.94 | MX$27.00 1.6 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€62.14 71.73 USD |
-0.5
|
€35.73B 41.24B USD | €0.00 0 USD | €62.14 71.73 USD | €62.14 71.73 USD | €35.73B 41.24B USD | 47.07 | €1.32 1.52 USD | ||
Genmab A/S
0MGB.IL
GB
|
DKK 3,497.00 512.73 USD |
+0.19
|
DKK 280.04B 41.06B USD | DKK 277.00 40.61 USD | DKK 0.00 0 USD | DKK 0.00 0 USD | DKK 280.04B 41.06B USD | 49.41 | DKK 70.77 10.38 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€60.73 70.1 USD |
0
|
€34.92B 40.31B USD | €150.00 173.15 USD | €60.73 70.1 USD | €62.39 72.02 USD | €34.92B 40.31B USD | 46.00 | €1.32 1.52 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩213,000 160.78 USD |
-0.93
|
₩49T 36.84B USD | ₩575K 433.93 USD | ₩211,000 159.27 USD | ₩216,500 163.42 USD | ₩49T 36.84B USD | 0 | ₩0 0 USD | ||
Revolution Medicines, Inc.
42Z.F
DE
|
€145.35 167.78 USD |
-2.02
|
€31.44B 36.29B USD | €55.00 63.49 USD | €143.75 165.94 USD | €145.35 167.78 USD | €31.44B 36.29B USD | 0 | -€7.99 -9.2 USD | ||
Genmab A/S
GE9.DE
DE
|
€473.70 546.81 USD |
0
|
€29.21B 33.72B USD | €66.00 76.19 USD | €468.00 540.23 USD | €475.60 549 USD | €29.21B 33.72B USD | 47.04 | €10.07 11.62 USD | ||
Insmed Incorporated
IM8N.F
DE
|
€130.98 151.19 USD |
+4.9
|
€28.73B 33.17B USD | €200.00 230.87 USD | €130.98 151.19 USD | €130.98 151.19 USD | €28.73B 33.17B USD | 0 | -€2.43 -2.8 USD | ||
Genmab A/S
GE91.F
DE
|
€46.60 53.79 USD |
0
|
€28.73B 33.17B USD | €62.00 71.57 USD | €46.40 53.56 USD | €46.60 53.79 USD | €28.73B 33.17B USD | 46.13 | €1.01 1.17 USD | ||
Insmed Incorporated
IM8N.SG
DE
|
€130.54 150.69 USD |
-0.59
|
€28.64B 33.06B USD | €0.00 0 USD | €130.50 150.64 USD | €131.20 151.45 USD | €28.64B 33.06B USD | 0 | -€2.45 -2.8 USD | ||
Genmab
GNMSF
US
|
$503.74 — |
-3.46
|
$31.06B — | $2.00 — | $535.00 — | $541.00 — | $31.06B — | 43.05 | $11.70 — |
|
|
Roivant Sciences Ltd.
87S.F
DE
|
€34.57 39.91 USD |
0
|
€25.05B 28.91B USD | €500.00 577.17 USD | €34.57 39.91 USD | €35.07 40.48 USD | €25.05B 28.91B USD | 0 | -€0.56 -0.6 USD | ||
Incyte Corporation
I1NC34.SA
BR
|
R$347.20 70.37 USD |
-0.57
|
R$141.54B 28.69B USD | R$163.00 33.04 USD | R$343.35 69.59 USD | R$364.35 73.85 USD | R$141.54B 28.69B USD | 67.54 | R$5.14 1.04 USD | ||
Incyte Corporation
INCY.MX
MX
|
MX$2,215.00 131.16 USD |
0
|
MX$451.49B 26.73B USD | MX$410.00 24.28 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$451.49B 26.73B USD | 64.03 | MX$34.59 2.05 USD | ||
Incyte Corporation
ICY.F
DE
|
€103.80 119.82 USD |
-2.31
|
€21.16B 24.42B USD | €30.00 34.63 USD | €103.80 119.82 USD | €103.80 119.82 USD | €21.16B 24.42B USD | 61.42 | €1.69 1.95 USD | ||
BioNTech SE
BNTXN.MX
MX
|
MX$1,650.00 97.7 USD |
0
|
MX$409.08B 24.22B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$409.08B 24.22B USD | 0 | -MX$120.50 -7.1 USD | ||
BioNTech SE
B1NT34.SA
BR
|
R$30.10 6.1 USD |
-1.67
|
R$119.40B 24.2B USD | R$1.07K 217.48 USD | R$30.10 6.1 USD | R$30.26 6.13 USD | R$119.40B 24.2B USD | 0 | -R$2.25 -0.4 USD | ||
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$44.24 8.97 USD |
+0.43
|
R$118.51B 24.02B USD | R$2.10K 426.04 USD | R$44.00 8.92 USD | R$44.88 9.1 USD | R$118.51B 24.02B USD | 8.50 | R$5.20 1.05 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$5.71 — |
+4.01
|
$23.50B — | $4.00K — | $6.45 — | $6.45 — | $23.50B — | 33.58 | $0.17 — |
|
|
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€4.80 5.54 USD |
-6.43
|
€19.76B 22.81B USD | €800.00 923.47 USD | €4.64 5.35 USD | €4.80 5.54 USD | €19.76B 22.81B USD | 32.00 | €0.15 0.17 USD | ||
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€9.20 10.62 USD |
-6.6
|
€18.94B 21.86B USD | €95.00 109.66 USD | €9.20 10.62 USD | €9.20 10.62 USD | €18.94B 21.86B USD | 31.72 | €0.29 0.33 USD | ||
BioNTech SE
BNTX.VI
AT
|
€75.05 86.63 USD |
-2.28
|
€18.61B 21.48B USD | €584.00 674.13 USD | €75.00 86.58 USD | €76.50 88.31 USD | €18.61B 21.48B USD | 0 | -€6.02 -6.9 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€135.80 156.76 USD |
0
|
€18.19B 21B USD | €407.00 469.81 USD | €134.55 155.32 USD | €138.10 159.41 USD | €18.19B 21B USD | 7.96 | €17.04 19.67 USD | ||
BioNTech SE
22UA.F
DE
|
€73.25 84.56 USD |
-1.01
|
€18.16B 20.96B USD | €10.00 11.54 USD | €73.25 84.56 USD | €73.25 84.56 USD | €18.16B 20.96B USD | 0 | -€5.88 -6.7 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€133.55 154.16 USD |
-1.22
|
€17.89B 20.65B USD | €25.00 28.86 USD | €133.55 154.16 USD | €133.55 154.16 USD | €17.89B 20.65B USD | 7.83 | €17.04 19.67 USD | ||
Innovent Biologics, Inc.
6IB.F
DE
|
€9.77 11.28 USD |
0
|
€17.04B 19.67B USD | €100.00 115.43 USD | €9.77 11.28 USD | €9.81 11.33 USD | €17.04B 19.67B USD | 122.12 | €0.08 0.09 USD | ||
Innovent Biologics
IVBXF
US
|
$10.93 — |
0
|
$19.06B — | $900.00 — | $11.00 — | $11.06 — | $19.06B — | 109.29 | $0.10 — |
|
|
Exelixis, Inc.
EX9.F
DE
|
€59.11 68.23 USD |
-4.85
|
€14.42B 16.65B USD | €20.00 23.09 USD | €59.11 68.23 USD | €59.11 68.23 USD | €14.42B 16.65B USD | 20.59 | €2.87 3.31 USD | ||
BridgeBio Pharma, Inc.
2CL.F
DE
|
€71.41 82.43 USD |
0
|
€13.91B 16.06B USD | €99.00 114.28 USD | €70.29 81.14 USD | €71.41 82.43 USD | €13.91B 16.06B USD | 0 | -€2.61 -3.01 USD | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€209.70 242.06 USD |
-2.33
|
€13.46B 15.54B USD | €50.00 57.72 USD | €209.70 242.06 USD | €209.70 242.06 USD | €13.46B 15.54B USD | 72.06 | €2.91 3.36 USD | ||
Sino Biopharmaceutical
SBHMY
US
|
$14.40 — |
0
|
$12.80B — | $200.00 — | $14.23 — | $14.40 — | $12.80B — | 37.89 | $0.38 — |
|
|
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€57.24 66.07 USD |
+4.22
|
€11.09B 12.8B USD | €0.00 0 USD | €55.26 63.79 USD | €57.24 66.07 USD | €11.09B 12.8B USD | 0 | -€0.08 -0.09 USD | ||
Bio-Techne Corporation
T1CH34.SA
BR
|
R$13.38 2.71 USD |
+0.07
|
R$63.06B 12.78B USD | R$0.00 0 USD | R$13.38 2.71 USD | R$13.38 2.71 USD | R$63.06B 12.78B USD | 70.42 | R$0.19 0.04 USD | ||
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,850.00 109.54 USD |
0
|
MX$210.92B 12.49B USD | MX$7.00 0.41 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$210.92B 12.49B USD | 26.20 | MX$70.60 4.18 USD | ||
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€55.52 64.09 USD |
-3.14
|
€10.75B 12.41B USD | €71.00 81.96 USD | €55.52 64.09 USD | €55.52 64.09 USD | €10.75B 12.41B USD | 0 | -€0.08 -0.09 USD | ||
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$157.60 31.94 USD |
0
|
R$61.05B 12.37B USD | R$0.00 0 USD | R$157.60 31.94 USD | R$157.60 31.94 USD | R$61.05B 12.37B USD | 0 | -R$0.26 -0.05 USD | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.59 0.68 USD |
-3.89
|
€10.40B 12.01B USD | €2.01K 2.32K USD | €0.59 0.68 USD | €0.59 0.68 USD | €10.40B 12.01B USD | 29.25 | €0.02 0.02 USD | ||
Financière de Tubize SA
FTD.SG
DE
|
€230.60 266.19 USD |
+0.96
|
€10.26B 11.85B USD | €0.00 0 USD | €226.60 261.57 USD | €230.60 266.19 USD | €10.26B 11.85B USD | 104.34 | €2.21 2.55 USD | ||
Sino Biopharmaceutical
SBMFF
US
|
$0.66 — |
0
|
$11.83B — | $1.00K — | $0.65 — | $0.65 — | $11.83B — | 33.25 | $0.02 — |
|
|
Bio-Techne Corporation
TE1.F
DE
|
€64.88 74.89 USD |
-3.16
|
€10.19B 11.77B USD | €10.00 11.54 USD | €64.88 74.89 USD | €64.88 74.89 USD | €10.19B 11.77B USD | 69.02 | €0.94 1.09 USD | ||
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$1,021.00 60.46 USD |
0
|
MX$197.76B 11.71B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$197.76B 11.71B USD | 0 | -MX$1.77 -0.1 USD | ||
Financière de Tubize SA
FTD.F
DE
|
€226.40 261.34 USD |
-2.83
|
€10.08B 11.63B USD | €225.00 259.73 USD | €226.40 261.34 USD | €226.40 261.34 USD | €10.08B 11.63B USD | 102.44 | €2.21 2.55 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€84.20 97.19 USD |
-2.79
|
€9.60B 11.08B USD | €15.00 17.32 USD | €84.20 97.19 USD | €84.20 97.19 USD | €9.60B 11.08B USD | 24.47 | €3.44 3.97 USD | ||
TG Therapeutics, Inc.
NKB2.F
DE
|
€58.40 67.41 USD |
-4.58
|
€8.83B 10.19B USD | €50.00 57.72 USD | €58.40 67.41 USD | €58.40 67.41 USD | €8.83B 10.19B USD | 100.68 | €0.58 0.67 USD | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€53.50 61.76 USD |
-1.83
|
€8.47B 9.78B USD | €0.00 0 USD | €53.50 61.76 USD | €53.50 61.76 USD | €8.47B 9.78B USD | 0 | -€6.93 -7.9 USD | ||
Krystal Biotech, Inc.
4KB.SG
DE
|
€284.50 328.41 USD |
-1.11
|
€8.43B 9.73B USD | €0.00 0 USD | €284.00 327.83 USD | €284.50 328.41 USD | €8.43B 9.73B USD | 44.94 | €6.33 7.31 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€282.90 326.56 USD |
-0.98
|
€8.38B 9.68B USD | €70.00 80.8 USD | €282.90 326.56 USD | €282.90 326.56 USD | €8.38B 9.68B USD | 44.69 | €6.33 7.31 USD | ||
Madrigal Pharmaceuticals, Inc.
YDO1.F
DE
|
€356.20 411.17 USD |
-1.55
|
€8.27B 9.55B USD | €11.00 12.7 USD | €356.20 411.17 USD | €356.20 411.17 USD | €8.27B 9.55B USD | 0 | -€5.04 -5.8 USD | ||
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$160.47B 9.5B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$160.47B 9.5B USD | 0 | -MX$121.10 -7.1 USD | ||
|
Nessun titolo preferito
Non hai ancora azioni preferite, aggiungile ai preferiti per visualizzarle qui |
|||||||||||


